Oncology Is a Major Focus for Many AI Drug Discovery Companies, Reports IDTechEx
- Thursday, October 7, 2021, 7:11
- PR Newswire
- Add a comment
BOSTON, Oct. 7, 2021 /PRNewswire/ — The application of artificial intelligence (AI) in the drug discovery process is promising to drastically cut down timelines and costs of bringing new therapies to patients. Typically, the development of a drug costs companies more than $1 billion, in…
About the Author
admin has written 21103 stories on this site.